What is Kodiak Sciences Inc's G&A?

Kodiak Sciences Inc (KOD) reported G&A of $11.23M in Q1 2026.

How has Kodiak Sciences Inc's G&A changed year-over-year?

Kodiak Sciences Inc's G&A decreased by 27.2% year-over-year, from $15.43M to $11.23M.

What is the long-term trend for Kodiak Sciences Inc's G&A?

Over 4 years (2021 to 2025), Kodiak Sciences Inc's G&A has grown at a 1.1% compound annual growth rate (CAGR), from $49.71M to $52.02M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Kodiak Sciences Inc KOD G&A

G&A at other companies

Ocular TherapeutixOCUL

$20.01M+22.4%

Vera TherapeuticsVERA

$39.12M+146%

Arcus BiosciencesRCUS

$29M+3.6%

Relay Therapeutics, Inc.RLAY

$11.03M-41.2%

PVL

Palvella TherapeuticsPVLA

$5.52M+45.4%

Kymera TherapeuticsKYMR

$20.36M+25.1%

Other financials

Income statement

See full

Operating income-$59.8M-1.2%

Net income-$58.2M-1.2%

EPS (diluted)-$0.94+13.8%

Balance sheet

See full

Cash & equivalents$169.5M+22.1%

Total debt$56.0M-17.2%

Total equity$112.1M+3.0%

Total assets$306.0M+2.7%

Cash flow

See full

Operating cash flow-$40.0M-37.6%

CapEx$942.0K+249%

Free cash flow-$41.0M-39.5%

Valuation

See full

Market cap$2.32B+1,477%

Enterprise value$2.2B+2,798%

Returns & leverage

See full

Return on equity-208.8%+2,306pp

Debt / equity0.5×-0.1×

Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kodiak Sciences Inc's G&A?: Kodiak Sciences Inc (KOD) reported G&A of $11.23M in Q1 2026.
How has Kodiak Sciences Inc's G&A changed year-over-year?: Kodiak Sciences Inc's G&A decreased by 27.2% year-over-year, from $15.43M to $11.23M.
What is the long-term trend for Kodiak Sciences Inc's G&A?: Over 4 years (2021 to 2025), Kodiak Sciences Inc's G&A has grown at a 1.1% compound annual growth rate (CAGR), from $49.71M to $52.02M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.